Khiron Life Sciences Corp.

A GLOBAL MEDICAL CANNABIS COMPANY

IMPROVING THE QUALITY OF PEOPLES' LIVES

TSXV: KHRN | OTCQX: KHRNF | FRANKFURT: A2JMZC

6
Countries:
Selling in Colombia, Peru, Germany, UK, Brazil and targeting Mexico for 2021
<50,000
Medical cannabis prescriptions filled year-to-date
<45%
Growth in medical cannabis sales Q3/21 vs. Q2/21
85%
Gross margin on medical cannabis products
<60%
Medical cannabis sales through insurance worldwide
157%
QoQ sales growth in Europe YTD 2021

Latest
Presentations

Recent Event

The Cannabis Conversation podcast: The recent developments in Germany in relation to cannabis legalization

OUR
BUSINESS UNITS

GLOBAL
EXPANSION

Khiron is well-positioned to take advantage of the emerging global cannabis opportunity.

OUR
PRODUCTION FACILITY

Cultivation: Upwards 0f 9 tonnes of dry flower. Fully licensed for commercial THC and CBD cultivation, extraction & sales in Colombia.

  • Total area of 20 Ha. Current cultivation area of 80,000 sq. ft.
  • ~1 MW Solar Park with capacity to reduce energy consumption by 40%

Our
Laboratory

  • State-of-the-art, 14,000 sq.ft. GMP-compliant post-harvest facility in Doima, Colombia (157 km. West of Bogota)
  • Extraction: Up to 3 tonnes of full-spectrum extract, with capacity to expand within the building

Leadership

KHIRON LIFE SCIENCES is led by a multidisciplinary and multicultural team with a unique understanding of various industries across Latin America and Europe


Investor
Contact

Paola Ricardo

T: 1 (647) 556-5750
investors@khiron.ca

Have a business-related question about KHRN? Or just general inquiries? Send us a message and we'll be happy to help.

Contact Us

Investor Email Alerts